PALX on OTC
Palomino Laboratories Inc.
American semiconductors and related devices company based in Goleta. Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
- TickerPALX on OTC1
- IndustrySemiconductors & Related Devices1
- HeadquartersGoleta, California1
- Incorporated inDE2
- Business address130 Castilian Drive, Suite 102, Goleta, Ca 931172
- Filer category, Emerging growth company2
- Legal formCorporation
See how the biggest companies compare on our leaderboards
September 29, 2025, Unite, through its wholly owned subsidiary Palomino Acquisition Co., consummated the Merger with Private Palomino.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| General and administrative | $2.7M | $6.1K |
| Total operating expenses | $2.7M | $6.1K |
| Loss from operations | -$2.7M | -$6.1K |
| Change in fair value of SAFE notes | -$461.3K | -$13.6K |
| Interest income | $890 | $3.5K |
| Net loss | -$3.2M | -$16.2K |
| Net loss per common share - basic | -$0.47 | -$0.01 |
| Net loss per common share - diluted | -$0.47 | -$0.01 |
| Weighted average common shares outstanding - basic | 6.7M shares | 1.5M shares |
| Weighted average common shares outstanding - dilutive | 6.7M shares | 1.5M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 5 fiscal years (annual) or 5 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2025-09-30 | 2024-12-31 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|
| Cash and cash equivalents | $8.1M | $134.7K | |||
| Prepaids and other current assets | $312.7K | $3.5K | |||
| Total current assets | $8.4M | $138.1K | |||
| Total assets | $8.4M | $138.1K | |||
| Accounts payable | $55.7K | $3.3K | |||
| Accrued expense and other liabilities | $280.8K | ||||
| Shareholder note | $3.1K | ||||
| Total current liabilities | $336.5K | $6.4K | |||
| SAFE notes | $150.0K | ||||
| Total liabilities | $336.5K | $156.4K | |||
| Common stock, $0.0001 par value; 300,000,000 shares authorized; 18,770,686 and 4,500,000 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $1.9K | $450 | |||
| Additional paid-in capital | $11.3M | -$390 | |||
| Accumulated deficit | -$3.2M | -$18.4K | |||
| Total stockholders equity (deficit) | $8.1M | -$18.3K | -$18.3K | -$2.1K | |
| Total liabilities and stockholders equity (deficit) | $8.4M | $138.1K | |||
| Preferred stock, par value | $0.00 | $0.00 | |||
| Preferred stock, shares authorized | 10.0M shares | 10.0M shares | |||
| Preferred stock, shares issued | 0 shares | 0 shares | |||
| Preferred stock, shares outstanding | 0 shares | 0 shares | |||
| Common stock, par value | $0.00 | $0.00 | $0.00 | ||
| Common stock, shares authorized | 300.0M shares | 300.0M shares | |||
| Common stock, shares issued | 18.8M shares | 4.5M shares | |||
| Common stock, shares outstanding | 18.8M shares | 4.5M shares |
| Period ending | 2025-12-31 | 2025-09-30 | 2024-12-31 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|
| Cash and cash equivalents | $8.1M | $134.7K | |||
| Prepaids and other current assets | $312.7K | $3.5K | |||
| Total current assets | $8.4M | $138.1K | |||
| Total assets | $8.4M | $138.1K | |||
| Accounts payable | $55.7K | $3.3K | |||
| Accrued expense and other liabilities | $280.8K | ||||
| Shareholder note | $3.1K | ||||
| Total current liabilities | $336.5K | $6.4K | |||
| SAFE notes | $150.0K | ||||
| Total liabilities | $336.5K | $156.4K | |||
| Common stock, $0.0001 par value; 300,000,000 shares authorized; 18,770,686 and 4,500,000 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $1.9K | $450 | |||
| Additional paid-in capital | $11.3M | -$390 | |||
| Accumulated deficit | -$3.2M | -$18.4K | |||
| Total stockholders equity (deficit) | $8.1M | -$18.3K | -$18.3K | -$2.1K | |
| Total liabilities and stockholders equity (deficit) | $8.4M | $138.1K | |||
| Preferred stock, par value | $0.00 | $0.00 | |||
| Preferred stock, shares authorized | 10.0M shares | 10.0M shares | |||
| Preferred stock, shares issued | 0 shares | 0 shares | |||
| Preferred stock, shares outstanding | 0 shares | 0 shares | |||
| Common stock, par value | $0.00 | $0.00 | $0.00 | ||
| Common stock, shares authorized | 300.0M shares | 300.0M shares | |||
| Common stock, shares issued | 18.8M shares | 4.5M shares | |||
| Common stock, shares outstanding | 18.8M shares | 4.5M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$3.2M | -$16.2K |
| Stock-based compensation related to employees and non-employees | $1.4M | |
| Change in fair value of SAFE notes | $461.3K | $13.6K |
| Prepaids and other current assets | -$309.2K | -$3.5K |
| Accounts payable and accrued expenses | $284.4K | $1.2K |
| Net cash used in operating activities | -$1.3M | -$4.9K |
| Proceeds from issuance of SAFE notes | $1.7M | |
| Proceeds from issuance of common stock and warrants in private placement | $9.8M | |
| Repayment of LPOF Note | -$349.2K | |
| Repayment of shareholder note | -$3.1K | |
| Payment of offering costs related to private placement | -$1.8M | |
| Proceeds from issuance of restricted stock awards | $20 | |
| Net cash provided by financing activities | $9.3M | |
| Net increase in cash and cash equivalents | $8.0M | -$4.9K |
| Recapitalization of Unite Acquisition 3 Corp. accumulated deficit at time of the exchange | -$398.1K | |
| Conversion of SAFE notes | $2.3M | |
| Common stock cancelled at the time of the exchange | $100 |
No quarter-by-quarter statement was filed.
Leadership
Who has led Palomino Laboratories Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
- Chief executive officerJeffrey Shealy Oct 27, 2025 to now9
- Chief executive officerNathan P. Pereira Nov 30, 2023 to Nov 30, 202310
- PresidentJeffrey Shealy Oct 27, 2025 to now9
- PresidentNathan P. Pereira Nov 30, 2023 to Nov 30, 202310
- Chief financial officerNathan P. Pereira Nov 30, 2023 to Nov 30, 202310
Board members and other officers (6)
- Chief Accounting OfficerJason Tu Oct 9, 2025 to now11
- SecretaryRichard Ogawa Oct 9, 2025 to now12
- Board memberRichard Ogawa Oct 9, 2025 to now12
- Board memberSteven Denbaars Oct 9, 2025 to now13
- Board memberJeffrey Shealy Oct 27, 2025 to now9
- Board memberNathan P. Pereira Nov 30, 2023 to Nov 30, 202310
Named in SEC Form D filings
People the company listed in its private-offering notices.
- Executive Officer, Director, PromoterNathan Pierra named Oct 14, 202514
Former names
- Unite Acquisition 3 Corp.Aug 10, 2023 to Aug 29, 20252
Timeline
Filings
52 filings to the SEC since October 2021: 3 annual reports, 9 quarterly reports, 8 major events, 10 insider forms, 6 large holders, 2 private raises, 14 other. The latest 20:
- Oct 14, 20268-K/A EDGAR
- Oct 8, 2026DEF 14A EDGAR
- Sep 28, 2026PRE 14A EDGAR
- Aug 21, 2026SCHEDULE 13D/A EDGAR
- Aug 5, 20268-K EDGAR
- Aug 5, 202610-Q EDGAR
- Aug 4, 20264 EDGAR
- Jul 16, 20268-K EDGAR
- May 15, 202610-Q EDGAR
- May 5, 20268-K EDGAR
- May 1, 2026D EDGAR
- Apr 24, 20268-K EDGAR
- Apr 20, 20264 EDGAR
- Apr 20, 20264 EDGAR
- Apr 9, 20268-K EDGAR
- Mar 31, 202610-K EDGAR
- Feb 12, 2026424B3 EDGAR
- Feb 9, 2026EFFECT EDGAR
- Feb 5, 2026CORRESP EDGAR
- Jan 23, 2026S-1 EDGAR
The 52 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
2 open-market trades by officers, directors and large owners since October 2021: 2 buys and 0 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | Ogawa RichardSecretary | Buy | 12,500 | $4.00 | $50.0K | Form 4 |
| Apr 20, 2026 | Denbaars StevenDirector | Buy | 12,500 | $4.00 | $50.0K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Richard OgawaSCHEDULE 13D/A, 2 filings Oct 8, 2025 to Aug 21, 202615
- Jeffrey ShealySCHEDULE 13D, 1 filing Oct 27, 202516
- Steven DenbaarsSCHEDULE 13D, 1 filing Oct 7, 202517
- Lucius Partners LLCSCHEDULE 13D/A, 2 filings Oct 6, 202518
Money raised
Private offerings the company reported to the SEC on Form D.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11SEC EDGARJason Tu, Chief Accounting Officer
- 12SEC EDGARRichard Ogawa, Secretary
- 13SEC EDGARSteven Denbaars, Board member
- 14
- 15
- 16
- 17
- 18